1533 related articles for article (PubMed ID: 30219074)
1. Organoid technology and applications in cancer research.
Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
[TBL] [Abstract][Full Text] [Related]
2. Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine.
Xu H; Jiao Y; Qin S; Zhao W; Chu Q; Wu K
Exp Hematol Oncol; 2018; 7():30. PubMed ID: 30534474
[TBL] [Abstract][Full Text] [Related]
3. Cancer organoid co-culture model system: Novel approach to guide precision medicine.
Yuan J; Li X; Yu S
Front Immunol; 2022; 13():1061388. PubMed ID: 36713421
[TBL] [Abstract][Full Text] [Related]
4. Cancer modeling meets human organoid technology.
Tuveson D; Clevers H
Science; 2019 Jun; 364(6444):952-955. PubMed ID: 31171691
[TBL] [Abstract][Full Text] [Related]
5. Organoid Models for Precision Cancer Immunotherapy.
Sun CP; Lan HR; Fang XL; Yang XY; Jin KT
Front Immunol; 2022; 13():770465. PubMed ID: 35450073
[TBL] [Abstract][Full Text] [Related]
6. Organoid technology in cancer precision medicine.
Xia X; Li F; He J; Aji R; Gao D
Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
[TBL] [Abstract][Full Text] [Related]
7. Organoids: approaches and utility in cancer research.
Zhou B; Feng Z; Xu J; Xie J
Chin Med J (Engl); 2023 Aug; 136(15):1783-1793. PubMed ID: 37365679
[TBL] [Abstract][Full Text] [Related]
8. Importance of organoids for personalized medicine.
Perkhofer L; Frappart PO; Müller M; Kleger A
Per Med; 2018 Nov; 15(6):461-465. PubMed ID: 30418092
[TBL] [Abstract][Full Text] [Related]
9. Patient-Derived Organoids for Precision Cancer Immunotherapy.
Grönholm M; Feodoroff M; Antignani G; Martins B; Hamdan F; Cerullo V
Cancer Res; 2021 Jun; 81(12):3149-3155. PubMed ID: 33687948
[TBL] [Abstract][Full Text] [Related]
10. Use and application of 3D-organoid technology.
Artegiani B; Clevers H
Hum Mol Genet; 2018 Aug; 27(R2):R99-R107. PubMed ID: 29796608
[TBL] [Abstract][Full Text] [Related]
11. Organoid technology: Current standing and future perspectives.
Shariati L; Esmaeili Y; Haghjooy Javanmard S; Bidram E; Amini A
Stem Cells; 2021 Dec; 39(12):1625-1649. PubMed ID: 33786925
[TBL] [Abstract][Full Text] [Related]
12. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.
Grassi L; Alfonsi R; Francescangeli F; Signore M; De Angelis ML; Addario A; Costantini M; Flex E; Ciolfi A; Pizzi S; Bruselles A; Pallocca M; Simone G; Haoui M; Falchi M; Milella M; Sentinelli S; Di Matteo P; Stellacci E; Gallucci M; Muto G; Tartaglia M; De Maria R; Bonci D
Cell Death Dis; 2019 Feb; 10(3):201. PubMed ID: 30814510
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
Ren X; Chen W; Yang Q; Li X; Xu L
J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
[TBL] [Abstract][Full Text] [Related]
14. Stem cell-derived organoids and their application for medical research and patient treatment.
Bartfeld S; Clevers H
J Mol Med (Berl); 2017 Jul; 95(7):729-738. PubMed ID: 28391362
[TBL] [Abstract][Full Text] [Related]
15. Personalized Cancer Medicine: An Organoid Approach.
Aboulkheyr Es H; Montazeri L; Aref AR; Vosough M; Baharvand H
Trends Biotechnol; 2018 Apr; 36(4):358-371. PubMed ID: 29366522
[TBL] [Abstract][Full Text] [Related]
16. Progress and perspective of organoid technology in cancer-related translational medicine.
Lin Y; Jiang L; He Q; Yuan M; Cao J
Biomed Pharmacother; 2022 May; 149():112869. PubMed ID: 35358798
[TBL] [Abstract][Full Text] [Related]
17. Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities.
Yang J; Huang S; Cheng S; Jin Y; Zhang N; Wang Y
Front Cell Dev Biol; 2021; 9():701429. PubMed ID: 34409036
[TBL] [Abstract][Full Text] [Related]
18. Organoids for Drug Discovery and Personalized Medicine.
Takahashi T
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():447-462. PubMed ID: 30113875
[TBL] [Abstract][Full Text] [Related]
19. Applications of Bioengineered 3D Tissue and Tumor Organoids in Drug Development and Precision Medicine: Current and Future.
Devarasetty M; Mazzocchi AR; Skardal A
BioDrugs; 2018 Feb; 32(1):53-68. PubMed ID: 29383499
[TBL] [Abstract][Full Text] [Related]
20. [Establishment and application of gastric and gastric cancer organoids].
Fan S; Yin J; Wang M; Guan W
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1315-1320. PubMed ID: 30506544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
